Topic Explorer
Back to DashboardSearch your own terms or jump into a curated topic to scan historic SEC comment letters and company responses.
Popular Topics
AI
AI, artificial intelligence, and machine learning references.
Cybersecurity
Cybersecurity incidents, controls, and breach response.
Revenue Recognition
Revenue recognition policy, timing, and contract accounting.
Internal Controls
Internal control over financial reporting and material weakness topics.
Liquidity
Liquidity pressure, cash runway, and financing needs.
China Exposure
China operations, PRC exposure, and related regulatory references.
Searching for all of: "internal control" , "internal controls" , "material weakness" and "icfr"
| Date | Type | Ticker | Company | Matched Terms | Snippet | Open |
|---|---|---|---|---|---|---|
| Jun. 10, 2025 | CORRESP | MKDW | MKDWELL Tech Inc. | ...likely to have any material adverse effect on our business, financial condition, cash-flow or results of operations. Item 15. Controls and Procedures Management's Annual Report on Internal Control over Financial Reporting, page 71 3. We note that you identified material weaknesses; however, you do not include a statement as to whether your internal control over financial re... | Open Filing Company View | |
| Mar. 12, 2025 | CORRESP | COOT | Australian Oilseeds Holdings Ltd | ...inancial Officer concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this Annual Report on Form 10-K as a result of the material weakness described below. Notwithstanding these material weaknesses, management has concluded that our financial statements included in this Annual Report on Form 10-K are fairly stated in... | Open Filing Company View | |
| Oct. 22, 2024 | UPLOAD | ILUS | Ilustrato Pictures International Inc. | ...For example, we note the following: •The risk factor on page 38 about "Section 404 of the Sarbanes-Oxley Act requires annual management assessments of the effectiveness of [y]our internal controls over financial reporting" is identical to the disclosure on page 29 of your Form 10-12G filed on October 19, 2022 that automatically went effective in December 2022. However, it... | Open Filing Company View | |
| Sep. 25, 2024 | CORRESP | MTCH | Match Group, Inc. | ...inancial information for a reasonable investor to make decisions. The Company also considered any impact to management's previous evaluation and assessment of the effectiveness of internal control over financial reporting (“ICFR”) and its disclosure controls and procedures. The Company maintains that our internal controls over financial reporting and disclosure controls and... | Open Filing Company View | |
| Feb. 1, 2024 | UPLOAD | CD | Chaince Digital Holdings Inc. | ...tem 15. Controls and Procedures, page 101 2.We acknowledge your response to prior comment 2. Please tell us whether the many shortcomings you identify in your response represent a material weakness in your internal control over financial reporting. If not, explain why not. FirstName LastNameShi Qiu Comapany NameMercurity Fintech Holding Inc. February 1, 2024 Page 2 FirstName... | Open Filing Company View | |
| May. 11, 2023 | CORRESP | IRME | IR-Med, Inc. | ...e. Please explain how you reached this conclusion. In this regard, we note the Item 4 disclosures in your Form 10-Q for the quarter ended September 30, 2022, indicate that the two material weaknesses identified in your assessment of internal controls over financial reporting (ICFR) as of December 31, 2021, were still not remediated. In light of this disclosure, as well as yo... | Open Filing Company View | |
| Apr. 27, 2023 | UPLOAD | IRME | IR-Med, Inc. | ...explain how you reached this conclusion. In this regard, we note the Item 4 disclosures in your Form 10-Q for the quarter ended September 30, 2022, indicate that the two material material weaknesses identified in your assessment of internal controls over financial reporting (ICFR) as of December 31, 2021, were still not remediated. In light of this disclosure, as well as yo... | Open Filing Company View | |
| Feb. 22, 2022 | CORRESP | AYTU | AYTU BIOPHARMA, INC | ..., page 106 1. We have the following comments related to your response to comment 1 in our letter dated February 3, 2022. Please amend your 10-K as follows: ● Clearly disclose that internal control over financial reporting (ICFR) and disclosure controls and procedures (DCP) are NOT effective at June 30, 2021, as required by Item 308(a)(3) of Regulation S-K. ● Remove the refe... | Open Filing Company View | |
| Feb. 22, 2022 | CORRESP | FUNI | Hypha Labs, Inc. | ..., 2021. The Company undertakes to use the correct Evaluation Date in future filings. U.S. Securities and Exchange Commission February 22, 2022 Page 2 2. We note your disclosure of material weaknesses in internal control over financial reporting and we also note that the material weaknesses pertain to the recognition and measurement of the financial statements. As such, pleas... | Open Filing Company View | |
| Sep. 30, 2019 | CORRESP | GNPX | Genprex, Inc. | ...ompany’s response. Form 10-K for the Fiscal Year Ended December 31, 2018 Item 9A. Controls and Procedures, page 84 1. Please tell us how you determined that a conclusion that your internal control over financial reporting (ICFR) was not effective as of December 31, 2018, did not impact your conclusion regarding the effectiveness of your disclosure controls and procedures (D... | Open Filing Company View | |
|
|
|
|
||||
|
|
|
|
||||
|
|
|
|
||||
|
|
|
|
||||
|
|
|
|
||||
|
|
|
|